article_snippet.sent: Breast cancer patients may be spared chemotherapy thanks to new tests that pinpoint genetic 'markers' Breast cancer patients may be spared chemotherapy thanks to new tests that pinpoint genetic 'markers' in the tumour and determine the tumour aggressiveness.
article_snippet.sent: If the newest of the tests, called EndoPredict, shows a low score, patients can opt not to have chemotherapy.
article_snippet.sent: Surgeon Hemant Singhal said: 'I think there is a good case for the NHS to use this test on the basis that the cost is balanced out by savings in not giving chemotherapy.'
article_snippet.sent: Professor Kefah Mokbel, consultant breast surgeon at St George's Hospital, London, said: 'With this test Professor Kefah Mokbel, consultant breast surgeon at St George's Hospital, London can help patients make an informed choice, whereas in the past Professor Kefah Mokbel, consultant breast surgeon at St George's Hospital, London have just given chemotherapy to almost everyone.'
article_snippet.sent: Professor Mokbel operated on Becca in December at the Princess Grace Hospital, London, and afterwards a sample of the tumour was sent away and tested using the EndoPredict.
highlights_snippet.sent: Breast cancer patients may be spared chemotherapy thanks to new tests .
  
highlights_snippet.sent: Tests pinpoint genetic 'markers' in tumour and determine aggressiveness .
  